Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

mTORC1 inhibition attenuates necroptosis through RIP1 inhibition-mediated TFEB activation.

Abe K, Yano T, Tanno M, Miki T, Kuno A, Sato T, Kouzu H, Nakata K, Ohwada W, Kimura Y, Sugawara H, Shibata S, Igaki Y, Ino S, Miura T.

Biochim Biophys Acta Mol Basis Dis. 2019 Dec 1;1865(12):165552. doi: 10.1016/j.bbadis.2019.165552. Epub 2019 Sep 6.

2.

Empagliflozin, an SGLT2 Inhibitor, Reduced the Mortality Rate after Acute Myocardial Infarction with Modification of Cardiac Metabolomes and Antioxidants in Diabetic Rats.

Oshima H, Miki T, Kuno A, Mizuno M, Sato T, Tanno M, Yano T, Nakata K, Kimura Y, Abe K, Ohwada W, Miura T.

J Pharmacol Exp Ther. 2019 Mar;368(3):524-534. doi: 10.1124/jpet.118.253666. Epub 2018 Dec 14.

PMID:
30552292
3.

Translational regulation by miR-301b upregulates AMP deaminase in diabetic hearts.

Tatekoshi Y, Tanno M, Kouzu H, Abe K, Miki T, Kuno A, Yano T, Ishikawa S, Ohwada W, Sato T, Niinuma T, Suzuki H, Miura T.

J Mol Cell Cardiol. 2018 Jun;119:138-146. doi: 10.1016/j.yjmcc.2018.05.003. Epub 2018 May 4.

PMID:
29733818
4.

Suppressed autophagic response underlies augmentation of renal ischemia/reperfusion injury by type 2 diabetes.

Muratsubaki S, Kuno A, Tanno M, Miki T, Yano T, Sugawara H, Shibata S, Abe K, Ishikawa S, Ohno K, Kimura Y, Tatekoshi Y, Nakata K, Ohwada W, Mizuno M, Miura T.

Sci Rep. 2017 Jul 13;7(1):5311. doi: 10.1038/s41598-017-05667-5.

5.

Suppression of autophagic flux contributes to cardiomyocyte death by activation of necroptotic pathways.

Ogasawara M, Yano T, Tanno M, Abe K, Ishikawa S, Miki T, Kuno A, Tobisawa T, Muratsubaki S, Ohno K, Tatekoshi Y, Nakata K, Ohwada W, Miura T.

J Mol Cell Cardiol. 2017 Jul;108:203-213. doi: 10.1016/j.yjmcc.2017.06.008. Epub 2017 Jun 21.

PMID:
28647341

Supplemental Content

Loading ...
Support Center